Marshall Wace »

Tscan Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2023-12-31 $645k 111k 5.83

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Spdr S&p 500 Etf Equity Option Call Option (SPY)
Alphabet Inc-a Equity Option Put Option (GOOGL)
Meta Platforms-a Common Stock (META)
Alphabet Inc-c Common Stock (GOOG)
Walmart Common Stock (WMT)
Abbvie Equity Option Put Option (ABBV)
Las Vegas Sands Common Stock (LVS)
Dr Horton Common Stock (DHI)
Ishares-leh 20 Equity Option Call Option (TLT)
Eli Lilly & Co Right Call Option
General Electric Common Stock (GE)

View all positions for Marshall Wace

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
EcoR1 Capital
BVF
Baker Bros. Advisors
Propel Bio Management
Vanguard Group
Deer Management
Alphabet
Simplify Asset Management
Standard Life Aberdeen
Stifel Financial
Marshall Wace
Millennium Management
NewEdge Wealth
Jane Street

View all funds holding Tscan Therapeutics